www.jforcs.com

Media PlannerJournal for Clinical Studies is the only Peer- Reviewed, Contemporary & Authoritative guide focusing on conducting Multisite Studies and Operations in Emerging Markets.

“ In just four volumes, the Journal for Clinical Studies has

become a vibrant and important journal in the field of

clinical research, with a focus on studies conducted across

the globe. The range of topics included is impressive,

and the authors bring readers a wider range of perspectives.

Also note worthy are the creation and implementation of

s several categories of contribution, such as the Watch pages,

which provide succinct and regular updates on central topics,

and the Special Feature category featuring papers that are

comprehensive reviews of particular aspect of clinical

reasearch. I have no doubt that the Journal will continute to

grow in the comming years ”.

J. Rick Turner, PhD

“Clinical Research Industry has grown around the world in an unparallel rate in the past few years. The global pharmaceuticalmarket is estimated at US$ 427 Billion and Research & Development cost is estimated at US$ 60-65 Billion annually. Two thirds of this amount is spent on Drug Development, I.e. approximately US$ 40 billion. Clinical Trials involve almost 70% oftime and money of new Drug Development. Cost of conducting Clinical Trials for a new drug is approximate US$ 200-250Million.” Institute of Clinical Research.

Journal for Clinical Studies is the only publication on the market that focuses on Multisite Studies & Operations in Emerging Markets

Pharmaceutical Industry’s vision to bring cure to all, need to bring medicines to market faster, and the intention to make healthcare available to all has seen trials being conducted in many locations.

The access to patients with varied gene pool,food and cultural habits and population exposed to specific diseases has seen regions like India, China, Russia, Eastern Europe, Africa, Middle East and Latin America become major sites for sponsorcompanies to conduct their Clinical Trials. These are the regions where the vast access to the term coined – “Naïve Patient Population” has seen many new Contract Research Companies offering comprehensive services in these areas. As well as global Cglobal CROs, successfully establishing themselves in these markets.

As with all global operations, operating under different regulatory guidelines, understanding different cultural and ethicalvalues, negotiating regional operational procedures and finding the right partner in Emerging Markets has remained a challenge for the research and development based,pharmaceutical, bio- pharmaceutical and medical devices companies.

JCS with its uniquely selected editorial advisory board will provide you with regional and country by country information on the emerging markets. Information that will enable you to prepare for, and avoid any last minute glitches on Pre Clinical and Clinical Management, Clinical Management, Trial Design, Regulatory, Validatory and Submission Issues, Subject Recruitment and Retention, Site Management, Data capture and Data collection, Logistics and Patient Information and Compliance. JCS uniquely brings you experiences in trials for Vaccine Development and emerging market diseases.

Why Advertise with JCS?

Journal for Clinical Studies is a globally distributed publication with an established presence across the World.

Each bi-monthly issue has a hard-copy distribution figure of 20,000 copies, providing strong access to the International Market.

Europe: 9,485USA & Canada: 8,625ROW: 1,900

Within Sponsor Companies Within Sponsor Companies

Journal for Clinical Studies is sent directly to key decision makers in the life science industry,addressing all stakeholders

80% of our subscribers read or look through JCS within one week of receiving their copy

90.9% of our subscribers would beextremely or very likely to refer JCS to a colleague orco-worker.

We are the only publication dedicated to

multisite studies and the conditions of

play in emerging markets.

6% CEO/ MD6% Heads of Lifes Science 9% Heads of R&D7% Heads of Clinical Supply 5% Heads of Procurement 6% Heads of Formulations Development7% Heads of Medical D7% Heads of Medical Devices5% Heads of Analytical Development 11% Heads of Clinical Trials9% Heads of Monitoring/ Regulatory Affairs 7% Heads of Logistics 9% QP, QC/QA

14% Corporate Managment 9% Laboratory 12% Heads of Research Projects7% Heads of Manufacturing 8 % Heads of Product Development 9% Heads of QC/ QA 7% 7% Health Economists 10% Heads of Purchasing 8% Logistics Managers 10% IT Management 6% Marketing and Sales.

Reader’s Perspective88 % of subscribers have renewed subscription year on year81 % of subscribers have read the last 6 issues

62 % of subscribers have kept copies of JCS

for future references

11 % of subscribe11 % of subscribers corrospond with authors

5.1 % new subsciption every year

Author’s Perspective 89% of authors have submitted furtherarticles 61 % Have requested reprints

42 % Had their article purchased

29 % Had their article searched by name

on JCS on JCS website

11 % Impact factor

Advertiser’s Perspective92 % of advertisers have repeated advertisments in JCS85 % Have utilised JCS online services

65 % Have advertised every consecutive year

55 % of advertisers chose JCS above other

industindustry publications

12 % Have requested bespoke distrubution

Circulation Profile

We publish scientific papers on studies conducted in emerging markets and emerging market diseases Network & Communications

Scientific Papers

This section covers latest technology in regards to data capture, and data collection in remoteaccess areas, recruitment and retention in naïve patient population, patient information, empowerment and compliance, translation services,logistics challenges and various other important issues.issues.

Technology &Logistics

In this section we feature articles on trials conducted on specific therapeutic areas. E.g. Cholera Vaccine study in South Africa,DiabetesStudy in India, CNS study in Eastern Europe. Etc.

Therapeutic Studies

This section consists of articles and features evaluating markets. We will bring you operating procedures and experiences in different geographic locations. You will find here trends,regulatory guidelines, opportunities andexperiences of potential markets for your studies

Market Evaluation

This section will hold a series of watch pages,a comprehensive guideline for issues you needto consider and check while preparing for your multisite trials.Watch Pages will cover:* Logistics * Insurance* Insurance* Regulatory * Investment* Cardiovascular Safety* Central Nervous System * Region & Country Focus

Watch Pages

Journal for Clincal Studies is divided into six sections, providing more access to information on the conditions of play in multisitestudies & emerging markets.

JCS Will Uniquely Cover: * Acute Diarrhoeal Illness * Acute Lower Respiratory Infections * Child Health * Women’s Health * HIV/ Aids * Vaccine - Preventable Disease * Malarie * Malnutrition & Under Nutrition * Leprosy * Reproductive & Mental Health * Tuberculosis - Montitoring & Evaluation * Food borne, Bacterial & Mycotic Disease * Transplant Research * Endocrine & Metabolic * Pandemic Disease

Subjects Covered in JCS * Archival * Calibration Validation * Bio- Equivalence Validation and Bio- Availability * Analytical Methods & Validation * Clinical Trial Strategies & Innovation * Trial Partners & CROs * EDC & Informational & Technology * Subject Recruitment & Retention Strategies * Central Labs, ECG & Core Labs * Imaging Labs * LIMS * Biotech & Clinical Research * SMO & The Investigation Site * Clinical Trials Packaging/ Materials Management * Logistics & Supply Chain

Therapeutic Areas Covered * Oncology * CNS * Cardiovascular * Infectious Diseases * Dermatology * Liver Diseases * Kidney Diseases * Ophthalmology * Immunology/ Haematology * Respiratory * Orthopaedic * Pain * Geriatric * Gastroenterology * Pathology * Pediatric

Journal for Clinical Studies delivers regulatory information directly from theregulatory authoroties in all the emerging countries. JCS has made direct collaboration with the likes of DCGI (India), SFDA (China), SACRA South Africa), SAUDI FDA, RZN Russia and many more.

We deliver critical information about the process of Managing Clinical Trialsin Emerging Markets. Pharmaceutical & BiPharmaceutical & Biotechnology companies, CRO, laboratory, regulatory, and Clinical Research Professionals read Journal for Clinical Studies to learn new solutions and strategies that can be applied to conducting clinical trials in naive patient population and multisite studies.

We offer unparalled insight into the potential and opportunities in selecting new destinations for clinical trials.JCS with its uniquely selected editorial advisory board will provide you with regional and countregional and country by country information on the emerging markets. Information that will enable you to prepare for, and avoid any last minute glitches on Pre Clinical and Clinical Management, Trial Design, Regulatory, Validatory and Submission Issues, Subject Recruitment and Retention, Site management, Data capture and Data collection, Logistics and Patient Information and Compliance. JCS uniquely brings you experiences in trials for Vaccine Development and emerging market diseases.

We work directly with regulatory authorities globally.

JCS is the only journal focused on providing information to the research and development based pharmaceutical,bio-pharmaceutical and medical devices industry in America and Europe on clinical trials procedures in Emerging Markets and Naive Patient Population.

Editorial Topics and Focal Areas

What Sets JCS Apart?

1

Bonus Distribution at Exhibitions & Conferences

CBI Comparator Studies Conference EU Jan 18-19th

2013, London UK

EFGCP Annual Conference Jan 24-25th

, Brussels, Belgium

ACT & CBI cardiovascular Risk Assessment Summit Jan 30-31, Arlington, VA

HIMSS Feb20-24, Las Vegas, NV

CBI Annual Forum on Clinical Trial Registries and Results Databases Feb 2013, London, UK

CBI Annual Forum on Late Phase Research Feb 2013, Amsterdam, UK

IIR Partnership in Clinical Trials March 5-7th

, Orlando, FL

DIA EDM TBD

Volume 5 Issue 1 - January 2013 Submission Deadline - 15th December 2012

Watch Pages

> FDA & EMA* > Logistics

> CNS > Cardiovascular Safety

> China Watch > Insurance

Market Evaluation

> India > China

> Singapore > Thailand

> Indonesia > Australasia

> Japan > Malaysia

Therapeutic Areas

> Stroke > Cardiovascular/Metabolic

> Food Borne > Bacterial & Mycotic

> Malaria > Gastroenteritis

> Orthopaedic

Special Features

> ABPM > Holter monitoring

> LIMS > Comparator Drug Supply

> Global Regulatory Framework – > Patient Facing Clinical Trials

What GCP means in the Global

Framework > Subject – Travel & Reimbursement

> Late Phase Clinical Trials > Investigator Payments

> Clinical Trials Equipment

* FDA & EMA Watch Page - Latest guidelines from FDA & EMA on foreign clinical Trials

* Market Evaluation Section will also carry features on Ethics Committees, IRBs, Ethics

Committee Approval, Investigator Registration, Patient Empowerment, Informed Consent,

Patient Reviews & Aftercare, Patient Recruitment & Retention Strategies, and Investigator

Payments.

Special Subsection

Paediatrics

Journal for Clinical Studies is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.jforcs.com website for Peer Review Protocol and Authors Guidelines.

2

Bonus Distribution at Exhibitions & Conferences

CBI Annual Clinical Trial Management Systems (CTMS) Mar 22-23rd

, 2013, Philadelphia, PA

DIA Annual Euro Meeting Mar 2012, TBD

CBI Biosimilars Summit Mar 2012, TBD

DIA/ FDA CDER/CBER Computational Science Annual Meeting TBD

ACRP Annual Meeting Apr 14-17th

, Houston, TX

CBI Annual Forum on Clinical Trial Registries and Result Databases Apr 2013, Philadelphia, PA

ICR Annual Spring Conference: Clinical Research sans Frontiers May 14-15th

, London

Special Features

> Trial Partners & CROs > Global Central Labs

> Imaging & Core Lab > Biosimilars

> Biotech & Clinical Research > Remote Data Acquisition/Analysis

> Preclinical & Phase I > Proof of Concept

> Translation Services > RIB & Ethics Review Boards

> Medical Devices > Patient Recruitment & Retention

Volume 5 Issue 2 – March 2013 Submission Deadline - 15th February 2013

Watch Pages

> FDA & EMA* > Cardiovascular Safety

> CNS > Logistics

> Middle East

Market Evaluation

> Sub Saharan Africa > South Africa

> Latin America

Therapeutics

> CNS / Neurology > Orthopaedic

> Nutrition/Malnutrition > Oncology

> Ophthalmology > Respiratory (COPD)

> Inflammatory diseases

The topics and subjects listed above are special features and focuses. Please refer to the media information for a list of general topics that will be featured in Journal for Clinical Studies throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – info@pharmapubs.com Current News and Press Releases can also emailed to the above email address and will be hosted at – www.jforcs.com, or featured in the JCS Weekly Newsletter at our discretion.

Special Subsection

Electronic Data Capture &

Data Management

3

Volume 5 Issue 3 – May 2013 Submission Deadline – 15th April 2013

Therapeutic Areas

> Paediatrics > Endocrine & Metabolic

> Metabolic Stress > Vaccine Development & Preventable Diseases

> Bronchodilation > Ophthalmology

Watch Pages

> FDA & EMA* > Cardiovascular Safety

> CNS > Logistics

> India > IMP Supplies > Insurance

Market Evaluation

> Middle East > North Africa

> Saudi Arabia > Egypt

> UAE > Tunisia

> Jordan > Libya

> Turkey > Algeria

Special Features

> QTc Prolongation/Cardiac Safety > PK/PD Studies

> BIO Equivalence & Bio – Availability > Pharmacovigilance & Risk Management

> Temperature& Time Sensitive Clinical Trials Logistics > Equipment Transportation & Customs > Clinical Trials Reimbursement > Site Management

Bonus Distribution at Exhibitions & Conferences

CBI Pharma/ Bio Boot Camp on Electronic Trial Master files May 16-17th, 2012, Philadelphia, PA

MAGI Clinical

Research Conference East May 20-23, Washington DC

CBI Annual Project Management and Clinical Trial Forecasting May 2012, TBD

Patient Reported Outcomes (PRO) May, Philadelphia, PA

ASCO Annual Meeting Jun 1-5th, Chicago, IL

Bio International Convention Jun 18-21st, Boston, MA

DIA Annual Meeting

* FDA & EMA Watch Page - Latest guidelines from FDA & EMA on foreign clinical Trials

* Market Evaluation Section will also carry features on Ethics Committees, IRBs, Ethics

Committee Approval, Investigator Registration, Patient Empowerment, Informed Consent,

Patient Reviews & Aftercare, Patient Recruitment & Retention Strategies, and Investigator

Payments.

Special Subsection

Patient Recruitment &

Retention

Journal for Clinical Studies is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.jforcs.com website for Peer Review Protocol and Authors Guidelines.

4

Volume 5 Issue 4 – July 2013 Submission Deadline – 15th June 2013

Watch Pages

> FDA & EMA* > Cardiovascular Safety

> CNS > Logistics

> Australasia Focus

Bonus Distribution at Exhibitions & Conferences

34th Annual Conference, , Germany, on 25-29 August 2013.

8th Annual Clinical Research in Emerging Countries 2013 - London

Market Evaluation

> Russia > CIS States > CEE States > Central Europe > Scandinavia

Therapeutic Areas

> TB Monitoring & Evaluation > Immunology/Haematology

> Cardiology > Paediatrics

> Gastroenteritis > CNS

> Oncology > Women’s Health

Special Features

> Clinical Trials Packaging/ Materials Management > Medical Devices & Trials > IVRS/IWRS > eCTD > Clinical Trials – Strategies & Innovation, Phase I – IV > CRAs Training & Evaluation > CDISC/CDASH

The topics and subjects listed above are special features and focuses. Please refer to the media information for a list of general topics that will be featured in Journal for Clinical Studies throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – info@pharmapubs.com Current News and Press Releases can also emailed to the above email address and will be hosted at – www.jforcs.com, or featured in the JCS Weekly Newsletter at our discretion.

Special Subsection

ePRO

5

Volume 5 Issue 5 – September 2013 Submission Deadline – 15th August 2013

Watch Pages

> FDA & EMA* > Cardiovascular Safety > CNS > Logistics > Insurance

Market Evaluation

> ASEAN Countries Focus > Australia & New Zealand

Therapeutic Areas

> Pain > Cardiovascular

> Renal & Hepatic Impairment > Diabetes

> Respiratory

Special Features

> Preclinical > Archival

> Imaging Labs/ Central Labs/

ECG & Core Labs > Calibration/Validation

> Recruitment & Retention > EDC – Datacapture & Evaluation

> Translation Systems > IMP Supplies

> Temperature Controlled

Packaging & Logistics > Time/ Temp. Data Logging & Monitoring

Bonus Distribution at Exhibitions & Conferences

CBI Registries and Post

Approval Studies Congress Sept 2012, Princeton, NJ

CPHI/ICSE Worldwide

IIR Clinical Business Expo TBD

IIR Partnerships in Clinical Trials Asia TBD

AAPS Annual Meeting Oct 14-27th, Chicago, IL

RAPS Oct27-30, Seattle, WA

MAGI’s Clinical Research Conference West TBD, San Diego, CA

* FDA & EMA Watch Page - Latest guidelines from FDA & EMA on foreign clinical Trials

* Market Evaluation Section will also carry features on Ethics Committees, IRBs, Ethics

Committee Approval, Investigator Registration, Patient Empowerment, Informed Consent,

Patient Reviews & Aftercare, Patient Recruitment & Retention Strategies, and Investigator

Payments.

Special Subsection

Comparator Drug Supply &

Named Patient Programmes

Journal for Clinical Studies is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.jforcs.com website for Peer Review Protocol and Authors Guidelines.

6

Volume 5 Issue 6 – November 2013 Submission Deadline – 15th October 2013

Watch Pages

> FDA & EMA* > Cardiovascular Safety

> CNS > Logistics

> Paediatrics

Market Evaluation

> South Korea > China

> Pakistan > Singapore

> Malaysia > Japan

Therapeutic Areas

> Renal & Hepatic Impairment > Reproductive & Maternal Health

> Transplant Research > Dermatology

> Oncology in Paediatrics

Special Features

> Analytical Methods & Validation > Imaging

> EDC & Information Technology > ePRO

> SMO & the Investigative Site > Patient Knowledge & Empowerment

> Remote Patient Monitoring > Logistics – Hazardous Cargo

> Customs Regulation

Bonus Distribution at Exhibitions & Conferences

CBI Annual Interactive Response Technologies for Clinical Trials, TBD

The topics and subjects listed above are special features and focuses. Please refer to the media information for a list of general topics that will be featured in Journal for Clinical Studies throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – info@pharmapubs.com Current News and Press Releases can also emailed to the above email address and will be hosted at – www.jforcs.com, or featured in the JCS Weekly Newsletter at our discretion.

Special Subsection

Vaccine Development

A fresh and dynamic organisaon dedicated to the lifescience Industry. A Winning Combinaon... ‘Going for Gold’

Pharma Publicaons, Tower Bridge Business Complex, London SE16 4DG, Tel: +44(0)207 237 2036, Email: Info@pharmapubs.com

www.jforcs.com

www.jforpc.com

www.ipimedia.com